Europe Veterinary Pain Management Market - Industry Trends and Forecast to 2032
Market Report I 2023-09-01 I 252 Pages I Data Bridge Market Research
Europe veterinary pain management market is expected to reach USD 779,744.79 thousand by 2030 from USD 535,409.78 thousand in 2022 growing at a CAGR of 5.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation
Europe Veterinary Pain Management Market, By Product Type (Analgesics, Corticosteroids, and Alpha 2 Agonists), Drug Type (Branded and Generic), Mode of Purchase (Prescription Based and OTC), Animal Type (Companion Animal and Production Animal), Pain Source (Chronic Pain, Acute Pain, Post-Operative Pain, and Dental Pain), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Parenteral, Oral, and Topical), End User (Veterinary Hospitals, Veterinary Clinics, Pet Shops, Animal Farms, Academic & Research Institutes, and Others), Country (Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Poland, Denmark, Sweden, Norway, Funland, and rest of Europe) - Industry Trends and Forecast to 2030
Overview of Europe Veterinary Pain Management Market Dynamics
Driver
- Rising incidences of pet diseases
Restraint
- High costs of pet care
Opportunity
- Technological advancements for pain management
Market Players
Some of the major market players operating in the Europe veterinary pain management market are listed below:
- Dechra Pharmaceuticals PLC
- Virbac
- Norbrook
- Durvet Animal Health Products
- Bimeda, Inc.
- Inovet ( A subsidiary of Orion Group)
- Chanelle Pharma
- Vetoquinol
- Elanco
- Merck & Co., Inc.
- Zoetis Services LLC
- Ceva Animal Health, LLC
TABLE OF CONTENTS
1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.3 OVERVIEW OF THE EUROPE VETERINARY PAIN MANAGEMENT MARKET 29
1.4 CURRENCY AND PRICING 31
1.5 LIMITATIONS 31
1.6 MARKETS COVERED 32
2 MARKET SEGMENTATION 35
2.1 MARKETS COVERED 35
2.2 GEOGRAPHICAL SCOPE 36
2.3 YEARS CONSIDERED FOR THE STUDY 37
2.4 DBMR TRIPOD DATA VALIDATION MODEL 38
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 41
2.6 MULTIVARIATE MODELLING 42
2.7 MARKET END USER COVERAGE GRID 42
2.8 PRODUCT LIFELINE CURVE 43
2.9 DBMR MARKET POSITION GRID 44
2.10 VENDOR SHARE ANALYSIS 45
2.11 SECONDARY SOURCES 46
2.12 ASSUMPTIONS 46
3 EXECUTIVE SUMMARY 47
4 PREMIUM INSIGHTS 50
4.1 PESTEL ANALYSIS 51
4.2 PORTER'S FIVE FORCES 52
4.3 BRAND REVENUE ANALYSIS 53
5 MARKET OVERVIEW 54
5.1 DRIVERS 56
5.1.1 INCREASING PET OWNERSHIP 56
5.1.2 ADVANCEMENTS IN VETERINARY MEDICINE 56
5.1.3 GROWING INCIDENCES OF PET DISEASES 57
5.1.4 INCREASED GOVERNMENT PROJECTS TO ENHANCE ANIMAL CARE 57
5.2 RESTRAINTS 58
5.2.1 INCREASING PET CARE COSTS 58
5.2.2 STRICT REGULATORY GUIDELINES 58?
5.3 OPPORTUNITIES 59
5.3.1 RISING R&D ACTIVITIES AND PRODUCT APPROVAL FOR VETERINARY PAIN MANAGEMENT 59
5.3.2 RISING POPULARITY OF NON- CONVENTIONAL TREATMENT APPROACHES 60
5.3.3 TECHNOLOGICAL ADVANCEMENTS 60
5.4 CHALLENGES 61
5.4.1 LIMITED AVAILABILITY OF VETERINARIANS 61
5.4.2 RESISTANCE TO MEDICATIONS 61
6 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE 62
6.1 OVERVIEW 63
6.2 ANALGESICS 64
6.2.1 ANTI- INFLAMMATORY (NSAIDS) 64
6.2.1.1 CARPROFEN 65
6.2.1.2 MELOXICAM 65
6.2.1.3 PHENYLBUTAZONE 65
6.2.1.4 ACETAMINOPHEN 65
6.2.1.5 FIROCOXIB 65
6.2.1.6 DERACOXIB 65
6.2.1.7 OTHERS 66
6.2.2 OPIOIDS 66
6.2.2.1 MU AGONISTS 66
6.2.2.1.1 METHADONE 67
6.2.2.1.2 MEPERIDINE 67
6.2.2.1.3 MORPHINE 67
6.2.2.1.4 OXYMORPHONE 67
6.2.2.1.5 OTHERS 67
6.2.2.2 PARTIAL MU AGONIST 67
6.2.2.2.1 BUPRENORPHINE 67
6.2.2.2.2 OTHERS 68
6.2.2.3 KAPPA AGONIST MU ANTAGONIST 68
6.2.2.3.1 BUTORPHANOL 68
6.2.2.3.2 OTHERS 68
6.3 CORTICOSTEROIDS 69
6.3.1 DEXAMETHASONE 69
6.3.2 PREDNISOLONE 69
6.3.3 PREDNISONE 69
6.3.4 OTHERS 70
6.4 ALPHA 2 AGONISTS 70?
7 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE 71
7.1 OVERVIEW 72
7.2 BRANDED 73
7.3 GENERIC 73
8 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE 74
8.1 OVERVIEW 75
8.2 PRESCRIPTION BASED 76
8.3 OTC 76
9 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 77
9.1 OVERVIEW 78
9.2 COMPANION ANIMAL 79
9.2.1 CANINE 80
9.2.2 EQUINE 80
9.2.3 FELINE 80
9.2.4 OTHERS 80
9.3 PRODUCTION ANIMAL 80
9.3.1 CATTLE 81
9.3.2 SWINE 81
9.3.3 POULTRY 81
9.3.4 FISH 81
9.3.5 OTHERS 81
10 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE 82
10.1 OVERVIEW 83
10.2 CHRONIC PAIN 84
10.3 ACUTE PAIN 85
10.4 POST OPERATIVE PAIN 85
10.5 DENTAL PAIN 86
11 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE 87
11.1 OVERVIEW 88
11.2 SOLID 89
11.2.1 TABLET 89
11.2.2 POWDER 90
11.2.3 OTHERS 90?
11.3 LIQUID 90
11.3.1 SOLUTION 90
11.3.2 SYRUP 91
11.3.3 SUSPENSION 91
11.3.4 OTHERS 91
11.4 SEMI SOLID 91
11.4.1 GEL 92
11.4.2 CREAM 92
11.4.3 OTHERS 92
12 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION 93
12.1 OVERVIEW 94
12.2 PARENTERAL 95
12.3 ORAL 96
12.4 TOPICAL 96
13 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY END USER 97
13.1 OVERVIEW 98
13.2 VETERINARY HOSPITALS 99
13.3 VETERINARY CLINICS 100
13.4 PET SHOPS 100
13.5 ANIMAL FARMS 101
13.6 ACADEMIC & RESEARCH INSTITUTES 101
13.7 OTHERS 102
14 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY GEOGRAPHY 103
14.1 EUROPE 104
14.1.1 GERMANY 112
14.1.2 FRANCE 119
14.1.3 U K 126
14.1.4 ITALY 133
14.1.5 SPAIN 140
14.1.6 NETHERLANDS 147
14.1.7 RUSSIA 154
14.1.8 SWITZERLAND 161
14.1.9 POLAND 168
14.1.10 BELGIUM 175
14.1.11 TURKEY 182
14.1.12 SWEDEN 189
14.1.13 DENMARK 196
14.1.14 NORWAY 203
14.1.15 FINLAND 210
14.1.16 REST OF EUROPE 217
15 EUROPE VETERINARY PAIN MANAGEMENT MARKET, COMPANY LANDSCAPE 224
15.1 COMPANY SHARE ANALYSIS: EUROPE 224
16 SWOT ANALYSIS 225
17 COMPANY PROFILE 226
17.1 ZOETIS SERVICES LLC 226
17.1.1 COMPANY SNAPSHOT 226
17.1.2 COMPANY SHARE ANALYSIS 226
17.1.3 PRODUCT PORTFOLIO 227
17.1.4 RECENT DEVELOPMENTS 227
17.2 ELANCO 228
17.2.1 COMPANY SNAPSHOT 228
17.2.2 REVENUE ANALYSIS 228
17.2.3 COMPANY SHARE ANALYSIS 229
17.2.4 PRODUCT PORTFOLIO 229
17.2.5 RECENT DEVELOPMENT 229
17.3 MERCK & CO., INC. 230
17.3.1 COMPANY SNAPSHOT 230
17.3.2 REVENUE ANALYSIS 230
17.3.3 COMPANY SHARE ANALYSIS 231
17.3.4 PRODUCT PORTFOLIO 231
17.3.5 RECENT DEVELOPMENT 231
17.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 232
17.4.1 COMPANY SNAPSHOT 232
17.4.2 COMPANY SHARE ANALYSIS 232
17.4.3 PRODUCT PORTFOLIO 233
17.4.4 RECENT DEVELOPMENT 233
17.5 VETOQUINOL 234
17.5.1 COMPANY SNAPSHOT 234
17.5.2 REVENUE ANALYSIS 234
17.5.3 COMPANY SHARE ANALYSIS 235
17.5.4 PRODUCT PORTFOLIO 235
17.5.5 RECENT DEVELOPMENTS 235?
17.6 BIMEDA, INC. 237
17.6.1 COMPANY SNAPSHOT 237
17.6.2 PRODUCT PORTFOLIO 237
17.6.3 RECENT DEVELOPMENT 237
17.7 CEVA ANIMAL HEALTH, LLC 238
17.7.1 COMPANY SNAPSHOT 238
17.7.2 PRODUCT PORTFOLIO 238
17.7.3 RECENT DEVELOPMENT 238
17.8 CHANELLE PHARMA 239
17.8.1 COMPANY SNAPSHOT 239
17.8.2 PRODUCT PORTFOLIO 239
17.8.3 RECENT DEVELOPMENT 239
17.9 DECHRA PHARMACEUTICALS PLC 240
17.9.1 COMPANY SNAPSHOT 240
17.9.2 REVENUE ANALYSIS 240
17.9.3 PRODUCT PORTFOLIO 241
17.9.4 RECENT DEVELOPMENTS 241
17.10 DURVET ANIMAL HEALTH PRODUCTS 242
17.10.1 COMPANY SNAPSHOT 242
17.10.2 PRODUCT PORTFOLIO 242
17.10.3 RECENT DEVELOPMENT 242
17.11 INOVET (A SUBSIDIARY OF ORION GROUP) 243
17.11.1 COMPANY SNAPSHOT 243
17.11.2 PRODUCT PORTFOLIO 243
17.11.3 RECENT DEVELOPMENTS 243
17.12 NORBROOK 245
17.12.1 COMPANY SNAPSHOT 245
17.12.2 PRODUCT PORTFOLIO 245
17.12.3 RECENT DEVELOPMENT 245
17.13 VIRBAC 246
17.13.1 COMPANY SNAPSHOT 246
17.13.2 REVENUE ANALYSIS 246
17.13.3 PRODUCT PORTFOLIO 247
17.13.4 RECENT DEVELOPMENT 247
18 QUESTIONNAIRE 248
19 RELATED REPORTS 252
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.